| Manuel O. Méndez Muñiz |
Manuel O. Méndez Muñiz is Chief Executive Officer & Director at Quotient Ltd. He is also Member of Latino Corporate Directors Association.
He previously occupied the position of General Manager-Diagnostics Business at Abbott Laboratories, Chief Commercial Officer & Senior Vice President at Quest Diagnostics, Inc., Senior Vice President-Global Commercial Operations at QIAGEN NV, Vice President-Marketing & Sales at OraSure Technologies, Inc., Vice President-Marketing & Sales at Thermo Fisher Scientific, Inc. and EVP-North American Commercial Operations at bioMérieux SA.
Mr. Méndez Muñiz received an undergraduate degree from Boston University and an MBA from Kellogg School of Management. |
| Steven Zuiderwijk |
Steven Zuiderwijk is Chief Strategy & Business Development Officer at Quotient Ltd.
In the past he occupied the position of Vice President of Koninklijke Philips NV.
Mr. Zuiderwijk received a graduate degree from Delft University of Technology and an MBA from INSEAD Asia Campus. |
| Ali J. Kiboro |
Ali J. Kiboro occupies the position of Chief Financial Officer of Quotient Ltd. Mr. Kiboro is also on the board of AmeriPath, Inc.
In his past career Mr. Kiboro was Vice President-Finance at Quest Diagnostics, Inc.
Mr. Kiboro received an MBA from The Wharton School of the University of Pennsylvania and an undergraduate degree from Duquesne University of The Holy Spirit. |
| Christine Ginocchio |
Presently, Christine Ginocchio is Chief Scientific & Medical Officer at Quotient Ltd.
In her past career Dr. Ginocchio held the position of Senior Vice President-Global Medical Affairs at bioMérieux SA. |
| Mohammad El Khoury |
Mohammad El Khoury is Chief Commercial Officer at Quotient Ltd.
In the past he held the position of President & Head-Global Sales at QIAGEN NV. |
| Esteban Uriarte |
Esteban Uriarte is Chief Manufacturing Operations Officer at Quotient Ltd.
He received an MBA from Inter American University and an undergraduate degree from Georgia Institute of Technology. |
| Michael Hausmann |
Currently, Michael Hausmann occupies the position of Chief Technology Officer for Quotient Ltd.
He received a doctorate from Max Planck Institute of Immunobiology & Epigenetics and a graduate degree from the University of Freiburg. |
| Christian Albrich |
Currently, Christian Albrich is Chief People Officer of Quotient Ltd.
In the past Mr. Albrich was Chief Human Resources Officer for Galderma Holding SA, Senior VP & Head-Global Human Resources at Actelion Ltd. and Director-Human Resources for Serono France Holding SA.
He received an MBA from ESSEC Business School. |
| Heino von Prondzynski |
Mr. Heino von Prondzynski is a Chairman at Quotient Ltd. and a Chairman-Supervisory Board at Epigenomics AG. He is on the Board of Directors at The Binding Site Group Ltd. and HTL-STREFA SA. Mr. von Prondzynski was previously employed as a Chairman by Nobel Biocare Holding AG, an Independent Director by Hospira, Inc., a Member-Supervisory Board by Koninklijke Philips NV, an Independent Director-Supervisory Board by QIAGEN NV, a Chief Executive Officer-Diagnostics Division by F. Hoffmann-La Roche Ltd., a Chief Executive Officer by Roche Diagnostics Corp., a President-Vaccines Division by Chiron Corp., a General Manager by Bayer AG, a General Manager by Bayer SA (Brazil), and a Chief Executive Officer by Roche Diagnostic Systems, Inc. He also served on the board at BB Medtech AG, CaridianBCT, Inc., I-MED Radiology Network Ltd. and Tecan Group AG /Basel Government Employees/. He received his undergraduate degree from the University of Münster. |
| Isabelle Buckle |
Isabelle Buckle is on the board of Ariana Pharmaceuticals SA and Quotient Ltd. and EVP-Technology Transfer & Industrial Partnership at Institut Pasteur.
In her past career she occupied the position of Head-Business Development for Aspira Women's Health, Inc., Chairman & Chief Executive Officer at InGen Biosciences SA, Global Head-European Accounts at Life Technologies BPD UK Ltd. and Global VP-Clinical Mass Spectrometry at Bruker Daltonics Ltd.
Isabelle Buckle received a doctorate from Université de Paris. |
| Zubeen Shroff |
Currently, Zubeen Shroff occupies the position of Chairman of SMP Pharmacy Solutions LLC and Managing Partner at Galen Collaborative Capital. Mr. Shroff is also on the board of Quotient Ltd. and Galen Evolve SPV LLC and Chairman of Westchester Medical Center Foundation, Principal at Specialized Health Products International, Inc. and Vice Chairman & Treasurer at Westchester Medical Center.
Zubeen Shroff previously occupied the position of Chairman for XLNT Veterinary Care, Inc., Principal at Wilkerson Group and Principal at Schering-Plough Pharmaceuticals.
Mr. Shroff received an undergraduate degree from Boston University and an MBA from The Wharton School of the University of Pennsylvania. |
| Brian McDonough |
Brian McDonough is on the board of Quotient Ltd. and Principal at DX Consulting Ltd.
Mr. McDonough previously occupied the position of Executive Head-Saint Louis Regional Blood Services at American Red Cross Biomedical Services, Chief Operating Officer-Blood Services at American Red Cross Biomedical Services, President-North American Blood Products at Pall Corp., Vice President-BioMedical Services at American Red Cross, Inc. and Vice President-Worldwide Marketing at Ortho-Clinical Diagnostics.
He received an undergraduate degree from Wichita State University and a graduate degree from Central Michigan University. |
| Frederick Stanislaus Hallsworth |
Frederick Stanislaus Hallsworth is Member of The Institute of Chartered Accountants of Scotland and on the board of 5 other companies.
He previously was Non-Executive Chairman at Forth Dimension Displays Ltd., Member of Inveresk Research Group, Inc., Partner at Deloitte & Touche, Inc., Head-TMC Practice at Deloitte Ltd., Head-Audit at Arthur Andersen (UK) and Director-Finance Committee at the University of Cambridge.
Mr. Hallsworth received an undergraduate degree from the University of Glasgow. |
| Thomas Aebischer |
Thomas Aebischer is on the board of Holcim (Australia) Pty Ltd., Quotient Ltd., Geocycle SBF Pty Ltd. and dormakaba Holding AG.
In his past career Mr. Aebischer occupied the position of Chief Financial Officer & Executive Vice President for LyondellBasell Industries NV Director, Chief Financial Officer & EVP at Lyondellbasell Advanced Polymers, Inc. and Chief Financial Officer & Executive Vice President for Lyondellbasell Co. (both are subsidiaries of LyondellBasell Industries NV), Chief Financial Officer for Apasco SA de CV, Chief Financial Officer of Holcim Ltd. Chief Financial Officer for Holcim Ltd. (Switzerland), Chief Financial Officer for Holcim (New Zealand) Ltd. and Chief Financial Officer, Treasurer & SVP at Holcim (US), Inc. (which are all subsidiaries of Holcim Ltd.), Chief Financial Officer & Director at RWDC Industries Pte Ltd., Senior Manager at PricewaterhouseCoopers LLP (Hong Kong) and Member of Swiss-American Chamber of Commerce. |
| Catherine Larue |
Catherine Larue is on the board of Genfit SA, Quotient Ltd., Fondation Arc en Ciel and ITTM SA.
In her past career she was Chief Executive Officer of Luxembourg Institute of Health, Director-Business Unit at Bio-Rad Laboratories, Inc., Executive Vice President-Biomarkers at Genfit SA, Director-Research & Development at Sanofi Diagnostics Pasteur, Inc., Chief Executive Officer at Integrated Biobank of Luxembourg and Director-External Affairs at Integrated Biobank of Luxembourg.
She received a doctorate from Université de Rouen Normandie, an MBA from St. John's University and a graduate degree from The International School of Management. |
| John Wilkerson |
Co-founded Galen in 1990. Dr. Wilkerson has focused on healthcare throughout his career, beginning as a Group Product Director for Ortho Diagnostics Inc., a Johnson & Johnson company. He was with Smith Barney as a Vice President specializing in medical analysis and research before moving to Channing, Weinberg & Co., Inc. in 1980 – the firm he purchased and turned into The Wilkerson Group, a leading healthcare consultancy sold to IBM. Dr. Wilkerson currently serves on the Board of Directors of several of Galen’s privately held portfolio companies including Cardiva, Quotient BioDiagnostics Holdings, and TPS. Dr. Wilkerson is the immediate past Chairman of Atlantic Health Systems, a New Jersey hospital system, is a trustee and former President of the Museum of American Folk Art and founder of the E. L. Rose Conservancy. He earned a Ph.D. from Cornell University and is a member of the Cornell University Council and immediate past Chairman of the College of Agricultural and Life Sciences advisory board. |
